Gene · 688
Papers3,365
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,365
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SOX9/Kruppel-like factor 5 and the infiltrating epidermal hyperplasia of hidradenitis suppurativa. | J Am Acad Dermatol | 2026 | 41740893 | PubTator, text mining | PubMed |
| A KLF5's domino effect drives metastatic pancreatic cancer. | Mol Cancer | 2026 | 41735991 | PubTator, text mining | PubMed |
| scTELL: a single-cell ATAC-seq tool for locus-specific transposable element identification in chromatin accessibility. | Mob DNA | 2026 | 41731605 | PubTator, text mining | PubMed |
| OTUD4 deubiquitination stabilizes EGFR and activates the PI3K/AKT pathway to promote the invasiveness of triple-negative breast cancer. | Cell Death Dis | 2026 | 41730840 | PubTator, text mining | PubMed |
| The impact of p53 mutation on tumor immune evasion: mechanistic insights and clinical implications. | Front Immunol | 2026 | 41727427 | PubTator, text mining | PubMed |
| Multi-scale systems toxicology defines a KLF5-centered adverse outcome pathway linking DEHP exposure to pancreatic cancer progression and signaling programs relevant to therapy tolerance. | Front Cell Dev Biol | 2026 | 41727317 | PubTator, text mining | PubMed |
| RWDisEnh+: Enhancing disease-enhancer association prediction through multiplex-heterogeneous networks. | PLoS One | 2026 | 41719301 | PubTator, text mining | PubMed |
| CRISPR screen of human pancreatic cancer xenografts identifies a KLF5 proliferation vulnerability through epigenetic modifiers NCAPD2 and MTHFD1. | Mol Cancer | 2026 | 41668133 | PubTator, text mining | PubMed |
| Distinct roles for SETα and SETβ in early cell fate decisions. | Nucleic Acids Res | 2026 | 41665009 | PubTator, text mining | PubMed |
| The effect of walnut consumption on the peripheral blood mononuclear cell transcriptome. | Genes Nutr | 2026 | 41654725 | PubTator, text mining | PubMed |
| RNF90 promotes hepatic steatosis by degrading CPT1α to suppress fatty acid oxidation. | J Biol Chem | 2026 | 41651430 | PubTator, text mining | PubMed |
| Integrative Omics Analysis Reveals the Potential Value of CEACAM6 in Pan-Gastrointestinal Cancers. | Immun Inflamm Dis | 2026 | 41640009 | PubTator, text mining | PubMed |
| Spotlights on ubiquitin-specific proteases in lung cancer: from multifaceted pathophysiological mechanisms to potential therapeutic targets. | PeerJ | 2026 | 41635813 | PubTator, text mining | PubMed |
| A Genome-Wide Association Study of Hidradenitis Suppurativa from the VA's Million Veteran Program. | Dermatology | 2026 | 41632728 | PubTator, text mining | PubMed |
| Early Reprogramming Intermediates Enable Direct Neuronal Conversion Via NGN2. | J Mol Neurosci | 2026 | 41632409 | PubTator, text mining | PubMed |
| MICALL2 promotes angiogenesis of colorectal cancer by regulating the EGFR/PI3K/AKT/KLF5/VEGFA axis. | Biochem Pharmacol | 2026 | 41617093 | PubTator, text mining | PubMed |
| NPM1c⁺-driven lncRNA dysregulation in AML: Mechanisms, Controversies and translational roadblocks. | Transl Oncol | 2026 | 41581315 | PubTator, text mining | PubMed |
| Single-Cell Regulatory Network Analysis Identifies Adjunctive Drug Candidates in Early Risankizumab-Treated Psoriasis. | Curr Pharm Des | 2026 | 41574526 | PubTator, text mining | PubMed |
| A titin missense variant drives atrial electrical remodeling and is associated with atrial fibrillation. | Elife | 2026 | 41569083 | PubTator, text mining | PubMed |
| Dynamic epigenetic and transcriptomic reprogramming during embryonic skin development in goose (Anser anser domesticus). | Funct Integr Genomics | 2026 | 41563550 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/688/papers?page=4